Leslie Rocher

794 total citations
21 papers, 605 citations indexed

About

Leslie Rocher is a scholar working on Surgery, Nephrology and Transplantation. According to data from OpenAlex, Leslie Rocher has authored 21 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Nephrology and 8 papers in Transplantation. Recurrent topics in Leslie Rocher's work include Renal Transplantation Outcomes and Treatments (8 papers), Organ Transplantation Techniques and Outcomes (6 papers) and Dialysis and Renal Disease Management (4 papers). Leslie Rocher is often cited by papers focused on Renal Transplantation Outcomes and Treatments (8 papers), Organ Transplantation Techniques and Outcomes (6 papers) and Dialysis and Renal Disease Management (4 papers). Leslie Rocher collaborates with scholars based in United States, Canada and South Africa. Leslie Rocher's co-authors include Paul VanVeldhuisen, John B. Sorensen, Gabriel M. Danovitch, Claudia Corwin, Philip F. Halloran, Mark D. Stegall, Mark A. Hardy, Robert A. Metzger, Charles F. Shield and Jimmy A. Light and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Academy of Dermatology and American Journal of Kidney Diseases.

In The Last Decade

Leslie Rocher

20 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Rocher United States 9 445 271 168 118 102 21 605
Miriam Zimmering Germany 16 254 0.6× 151 0.6× 112 0.7× 90 0.8× 267 2.6× 21 683
S. Alexander United States 11 227 0.5× 179 0.7× 40 0.2× 108 0.9× 214 2.1× 18 582
Kelly Weigel United States 7 193 0.4× 196 0.7× 55 0.3× 59 0.5× 166 1.6× 11 505
William D. Payne United States 9 578 1.3× 453 1.7× 111 0.7× 219 1.9× 80 0.8× 14 859
Madelon van Agteren Netherlands 11 371 0.8× 121 0.4× 45 0.3× 69 0.6× 160 1.6× 24 607
Lynn A. Donaldson United States 11 268 0.6× 173 0.6× 68 0.4× 192 1.6× 299 2.9× 15 660
K.K. Venkat United States 17 361 0.8× 186 0.7× 96 0.6× 118 1.0× 135 1.3× 40 620
R Marcén Spain 12 178 0.4× 139 0.5× 33 0.2× 64 0.5× 126 1.2× 32 399
Manoj R. Gumber India 14 203 0.5× 196 0.7× 38 0.2× 281 2.4× 96 0.9× 56 614
Muhammad A. Mujtaba United States 14 295 0.7× 251 0.9× 21 0.1× 128 1.1× 78 0.8× 56 490

Countries citing papers authored by Leslie Rocher

Since Specialization
Citations

This map shows the geographic impact of Leslie Rocher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Rocher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Rocher more than expected).

Fields of papers citing papers by Leslie Rocher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Rocher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Rocher. The network helps show where Leslie Rocher may publish in the future.

Co-authorship network of co-authors of Leslie Rocher

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Rocher. A scholar is included among the top collaborators of Leslie Rocher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Rocher. Leslie Rocher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wei, et al.. (2014). Natural Killer Cells are Involved in both Acute Antibody Mediated Rejection and Acute Cellular Rejection. American Journal of Clinical Pathology. 142(suppl_1). A220–A220. 1 indexed citations
2.
Parasuraman, Ravi, et al.. (2013). Severe Necrotizing Adenovirus Tubulointerstitial Nephritis in a Kidney Transplant Recipient. SHILAP Revista de lepidopterología. 2013. 1–5. 12 indexed citations
3.
Parasuraman, Ravi, et al.. (2013). Renal Allograft Outcome in Recipients of Positive-Crossmatch Combined Liver-Kidney Transplantation. Transplantation Proceedings. 45(9). 3269–3272. 10 indexed citations
4.
Parasuraman, Ravi, Ping L. Zhang, Leslie Rocher, et al.. (2011). Primary Nonfunction of Renal Allograft Secondary to Acute Oxalate Nephropathy. SHILAP Revista de lepidopterología. 2011. 1–4. 7 indexed citations
5.
McCullough, Peter A., Leslie Rocher, Ravi Nistala, & Adam Whaley‐Connell. (2008). Chronic kidney disease as a cardiovascular risk state and considerations for the use of statins. Journal of clinical lipidology. 2(5). 318–327. 1 indexed citations
6.
Carpenter, Christopher, et al.. (2008). Disseminated Mycobacterium haemophilum Infection in a Renal Transplant Recipient Complicated by Immune Reconstitution and Hypercalcemia. Infectious Diseases in Clinical Practice. 16(6). 395–397.
7.
McCullough, Peter A. & Leslie Rocher. (2007). Statin therapy in renal disease: Harmful or protective?. Current Diabetes Reports. 7(6). 467–473. 2 indexed citations
8.
McCullough, Peter A. & Leslie Rocher. (2007). Statin therapy in renal disease: Harmful or protective?. Current Atherosclerosis Reports. 9(1). 18–24. 6 indexed citations
9.
Gonwa, Thomas A., Christopher P. Johnson, Nasimul Ahsan, et al.. (2003). Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Transplantation. 75(12). 2048–2053. 114 indexed citations
10.
11.
Johnson, Christopher P., Nasimul Ahsan, Thomas A. Gonwa, et al.. (2000). RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2. Transplantation. 69(5). 834–841. 229 indexed citations
12.
13.
Rocher, Leslie. (1996). Radiocontrast-induced acute renal failure. ACC Current Journal Review. 5(3). 75–78. 2 indexed citations
14.
Rocher, Leslie. (1990). Diabetic Nephropathy. Archives of Internal Medicine. 150(1). 26–26. 2 indexed citations
15.
Swartz, Richard D., et al.. (1990). The Curled Catheter: Dependable Device for Percutaneous Peritoneal Access. Peritoneal Dialysis International. 10(3). 231–235. 45 indexed citations
16.
Ellis, Charles N., Michael Goldfarb, Kevin D. Cooper, et al.. (1989). Cyclosporine A. Clinics in Dermatology. 7(3). 98–110. 8 indexed citations
17.
Swartz, Richard D., et al.. (1989). Disconnect during Continuous Ambulatory Peritoneal Dialysis (CAPD): Retrospective Experience with Three Different Systems. Peritoneal Dialysis International. 9(3). 175–178. 10 indexed citations
18.
Swartz, Richard D., et al.. (1989). Acinetobacter Peritonitis During Chronic Peritoneal Dialysis. American Journal of Kidney Diseases. 14(2). 101–104. 28 indexed citations
19.
Rosenberg, Lawrence, Robert M. Merion, Darrell A. Campbell, et al.. (1988). Peripheral blood catalase in patients undergoing renal transplantation. Journal of Surgical Research. 44(5). 493–498. 2 indexed citations
20.
Da, Campbell, et al.. (1987). Diagnosis of rejection in simultaneous renal/pancreas (urinary bladder drained) transplantation.. PubMed. 19(1 Pt 3). 2345–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miriam Zimmering Breakdown of academic impact, for papers by S. Alexander Breakdown of academic impact, for papers by Kelly Weigel Breakdown of academic impact, for papers by William D. Payne Breakdown of academic impact, for papers by Madelon van Agteren Breakdown of academic impact, for papers by Lynn A. Donaldson Breakdown of academic impact, for papers by K.K. Venkat Breakdown of academic impact, for papers by R Marcén Breakdown of academic impact, for papers by Manoj R. Gumber Breakdown of academic impact, for papers by Muhammad A. Mujtaba
Rankless by CCL
2026